United Kingdom· GB-APID-31516211000001105
Tinzaparin sodium 40,000units/2ml solution for injection vials
A tinzaparin product containing tinzaparin, registered in United Kingdom by J M McGill Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tinzaparin is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Tinzaparin · ATC B01AB10
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tinzaparin
- Manufacturer
- J M McGill Ltd
- Country
- United Kingdom (GB)
- ATC code
- B01AB10
- ATC class
- Tinzaparin
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
162 interactions on record for tinzaparin.
Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tinzaparin · interactions on record
162 records
- 94 severe
- 68 moderate
Most severe, free to view
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tinzaparin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsInnohep 10.000 IE anti-Xa/0,5 ml, oplossing voor injectieEuro Registratie Collectief B.V.
- SwedenInnohep 10 000 anti-Xa IE Injektionsvätska, lösning i förfylld sprutaLEO Pharma AB
- SpainINNOHEP 10.000 UI ANTI-XA/0,5 ML SOLUCION INYECTABLE EN JERINGAS PRECARGADASLeo Pharma A/S
- ItalyINNOHEP*10 siringhe 12.000 UI 0,6 mlLEO PHARMA A/S
- FranceINNOHEP 10 000 UI anti-Xa/0,5 ml, solution injectable en seringue préremplieLABORATOIRES LEO
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Greece · Innohep
- Sweden · Innohep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15a64dfa-bed8-423c-b985-cd5db6291ce8 GET /v1/drugs/15a64dfa-bed8-423c-b985-cd5db6291ce8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "31516211000001105",
"desc": "Tinzaparin sodium 40,000units/2ml solution for injection vials (J M McGill Ltd)",
"form": "Solution for injection",
"vpid": "35919511000001105",
"source": "dmd",
"vtm_id": "777776004",
"strength": "20000 unit",
"substance": "Tinzaparin",
"ingredient": "Tinzaparin sodium",
"supplier_code": "22403711000001101"
}See everything about tinzaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.